Forde H - Search Results

1

Impact of glycaemic technologies on quality of life and related outcomes in adults with type 1 diabetes: A narrative review.

Speight J, Choudhary P, Wilmot EG, Hendrieckx C, Forde H, Cheung WY, Crabtree T, Millar B, Traviss-Turner G, Hill A, Ajjan RA. Speight J, et al. Among authors: forde h. Diabet Med. 2023 Jan;40(1):e14944. doi: 10.1111/dme.14944. Epub 2022 Sep 26. Diabet Med. 2023. PMID: 36004676 Free PMC article. Review.

2

Letter to the editor.

Forde H, Wilmot EG, Choudhary P. Forde H, et al. Diabet Med. 2021 Jul;38(7):e14546. doi: 10.1111/dme.14546. Epub 2021 Mar 3. Diabet Med. 2021. PMID: 33616262 No abstract available.

3

Current provision and HCP experiences of remote care delivery and diabetes technology training for people with type 1 diabetes in the UK during the COVID-19 pandemic.

Forde H, Choudhary P, Lumb A, Wilmot E, Hussain S. Forde H, et al. Diabet Med. 2022 Apr;39(4):e14755. doi: 10.1111/dme.14755. Epub 2021 Dec 21. Diabet Med. 2022. PMID: 34862815

4

Remote consultations for diabetes care in a post COVID-19 world.

Forde H, Choudhary P, Hammond P, Hussain S. Forde H, et al. Diabet Med. 2023 Mar;40(3):e14977. doi: 10.1111/dme.14977. Epub 2022 Oct 22. Diabet Med. 2023. PMID: 36251424 Free PMC article. No abstract available.

5

Glucose sensing technology-current practice?

Forde HE, Browne S, Smith D, Tormey WP. Forde HE, et al. Ir J Med Sci. 2019 Feb;188(1):125-127. doi: 10.1007/s11845-018-1800-7. Epub 2018 Apr 4. Ir J Med Sci. 2019. PMID: 29619681 No abstract available.

6

Parathyroid adenoma in a patient with familial hypocalciuric hypercalcaemia.

Forde HE, Hill AD, Smith D. Forde HE, et al. BMJ Case Rep. 2014 Oct 15;2014:bcr2014206473. doi: 10.1136/bcr-2014-206473. BMJ Case Rep. 2014. PMID: 25320261 Free PMC article.

7

The effects of insulin and liraglutide on osteoprotegerin and vascular calcification in vitro and in patients with type 2 diabetes.

Davenport C, Mahmood WA, Forde H, Ashley DT, Agha A, McDermott J, Sreenan S, Thompson CJ, McGrath F, McAdam B, Cummins PM, Smith D. Davenport C, et al. Among authors: forde h. Eur J Endocrinol. 2015 Jul;173(1):53-61. doi: 10.1530/EJE-14-1137. Eur J Endocrinol. 2015. PMID: 26036811

8

The beneficial pleiotropic effects of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) within the vasculature: A review of the evidence.

Forde H, Harper E, Davenport C, Rochfort KD, Wallace R, Murphy RP, Smith D, Cummins PM. Forde H, et al. Atherosclerosis. 2016 Apr;247:87-96. doi: 10.1016/j.atherosclerosis.2016.02.002. Epub 2016 Feb 9. Atherosclerosis. 2016. PMID: 26878368 Review.

9

Vascular calcification in type-2 diabetes and cardiovascular disease: Integrative roles for OPG, RANKL and TRAIL.

Harper E, Forde H, Davenport C, Rochfort KD, Smith D, Cummins PM. Harper E, et al. Among authors: forde h. Vascul Pharmacol. 2016 Jul;82:30-40. doi: 10.1016/j.vph.2016.02.003. Epub 2016 Feb 24. Vascul Pharmacol. 2016. PMID: 26924459 Review.

10

The contribution of undiagnosed adrenal insufficiency to euvolaemic hyponatraemia: results of a large prospective single-centre study.

Cuesta M, Garrahy A, Slattery D, Gupta S, Hannon AM, Forde H, McGurren K, Sherlock M, Tormey W, Thompson CJ. Cuesta M, et al. Among authors: forde h. Clin Endocrinol (Oxf). 2016 Dec;85(6):836-844. doi: 10.1111/cen.13128. Epub 2016 Jul 12. Clin Endocrinol (Oxf). 2016. PMID: 27271953

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page